Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
5.51
-0.02 (-0.36%)
At close: Mar 6, 2026, 4:00 PM EST
5.40
-0.11 (-2.00%)
After-hours: Mar 6, 2026, 7:42 PM EST
Compass Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -66.49 | -49.38 | -42.49 | -39.23 | -82.18 | |
| Depreciation & Amortization | 1.47 | 1.75 | 1.89 | 1.9 | 1.62 | |
| Loss (Gain) From Sale of Assets | - | - | - | -0.07 | -0.04 | |
| Asset Writedown & Restructuring Costs | - | - | - | - | 50.62 | |
| Loss (Gain) From Sale of Investments | -1.67 | -1.65 | -3.23 | -0.8 | - | |
| Stock-Based Compensation | 8.37 | 8.56 | 6.12 | 5.33 | 4.03 | |
| Other Operating Activities | - | - | - | - | 0.04 | |
| Change in Accounts Payable | -0.66 | -1.84 | 0.71 | 2.52 | -0.19 | |
| Change in Other Net Operating Assets | 9.84 | -2.3 | -3.62 | -3.78 | 6.44 | |
| Operating Cash Flow | -49.14 | -44.86 | -40.62 | -34.13 | -19.67 | |
| Capital Expenditures | -0.03 | -0.04 | -0.03 | -0.21 | -1.89 | |
| Sale of Property, Plant & Equipment | - | - | - | 0.18 | 0.12 | |
| Investment in Securities | -93.28 | 46.82 | 27 | -151.16 | - | |
| Investing Cash Flow | -93.31 | 46.77 | 26.97 | -151.2 | -1.77 | |
| Long-Term Debt Repaid | - | - | - | - | -9.38 | |
| Net Debt Issued (Repaid) | - | - | - | - | -9.38 | |
| Issuance of Common Stock | 139.27 | 18.11 | 3.19 | 76.25 | 128.27 | |
| Repurchase of Common Stock | -1.03 | -0.23 | -0.16 | - | - | |
| Other Financing Activities | -8.64 | -0.54 | -0.09 | -0.5 | -0.28 | |
| Financing Cash Flow | 129.61 | 17.34 | 2.94 | 75.76 | 118.61 | |
| Miscellaneous Cash Flow Adjustments | - | 0.57 | - | - | - | |
| Net Cash Flow | -12.84 | 19.82 | -10.72 | -109.57 | 97.18 | |
| Free Cash Flow | -49.17 | -44.9 | -40.65 | -34.34 | -21.55 | |
| Free Cash Flow Margin | - | -5282.23% | - | - | - | |
| Free Cash Flow Per Share | -0.31 | -0.33 | -0.32 | -0.33 | -0.34 | |
| Cash Interest Paid | - | - | - | - | 0.37 | |
| Levered Free Cash Flow | -26.16 | -27.8 | -25.2 | -19.17 | -8.46 | |
| Unlevered Free Cash Flow | -26.16 | -27.8 | -25.2 | -19.17 | -8.23 | |
| Change in Working Capital | 9.18 | -4.14 | -2.91 | -1.26 | 6.25 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.